COZAAR Drug Patent Profile

When do Cozaar patents expire, and what generic alternatives are available?

Cozaar is a drug marketed by Organon and is included in one NDA.

The generic ingredient in COZAAR is losartan potassium. There are thirty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Cozaar

A generic version of COZAAR was approved as losartan potassium by ALEMBIC PHARMS LTD on October 6^th, 2010.

Summary for COZAAR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	187
Clinical Trials:	78
Patent Applications:	4,336
Drug Prices:	Drug price information for COZAAR
What excipients (inactive ingredients) are in COZAAR?	COZAAR excipients list
DailyMed Link:	COZAAR at DailyMed

See drug prices for COZAAR

See drug sales revenues for COZAAR

Recent Clinical Trials for COZAAR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mayo Clinic	Phase 3
National Heart, Lung, and Blood Institute (NHLBI)	Phase 3
Actuate Therapeutics	Phase 2

See all COZAAR clinical trials

Pharmacology for COZAAR

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

US Patents and Regulatory Information for COZAAR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995	AB	RX	Yes	No
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-002	Apr 14, 1995	AB	RX	Yes	No
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998	AB	RX	Yes	Yes

Expired US Patents for COZAAR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-003	Oct 13, 1998
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995
Organon	COZAAR	losartan potassium	TABLET;ORAL	020386-001	Apr 14, 1995

International Patents for COZAAR

See the table below for patents covering COZAAR around the world.

Country	Patent Number	Title	Estimated Expiration
Netherlands	950009
Russian Federation	1814646	METHOD OF SYNTHESIS OF IMIDAZOLE DERIVATIVES
Portugal	85312	PROCESSO PARA A PREPARACAO DE IMIDAZOIS BLOQUEADORES DOS RECEPTORES DE ANGIOTENSINA II E DE COMPOSICOES FARMACEUTICAS QUE OS CONTEM
Russian Federation	2017733	IMIDAZOLE DERIVATIVES

Supplementary Protection Certificates for COZAAR

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0253310	SPC/GB95/010	United Kingdom		PRODUCT NAME: 2-N-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL) METHYL) -5-(HYDROXYMETHYL) IMIDAZOLE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT; REGISTERED: SE 12209 19940902; UK 0025/0324 19941215; UK 0025/0336 19941215
0253310	SZ 16/1996	Austria		PRODUCT NAME: LOSARTAN-KALIUM
0733366	SZ 25/1998	Austria		PRODUCT NAME: LOSARTAN-KALIUM UND HYDROCHLOROTHIAZID
0733366	98C0030	Belgium		PRODUCT NAME: KALII LOSARTAN, HYDROCHLOROTHIAZIDUM; NAT. REGISTRATION NO/DATE: 922 IS 174 F 3 19980223; FIRST REGISTRATION: FR 338 520.7 19950215